Hiromasa Yamamoto Selected Research

Hiromasa Yamamoto Research Topics

Disease

58	Neoplasms (Cancer) 05/2024 - 07/2006
39	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 02/2008
34	Lung Neoplasms (Lung Cancer) 04/2024 - 07/2006
11	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2015
10	Malignant Mesothelioma 06/2019 - 11/2008
6	Adenocarcinoma of Lung 06/2020 - 07/2006
5	Sarcoma (Soft Tissue Sarcoma) 12/2023 - 02/2016
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2010
5	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 02/2005
4	COVID-19 01/2023 - 01/2021
3	Bronchiolitis Obliterans Syndrome 11/2023 - 02/2022
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2023 - 01/2021
3	Hemorrhage 01/2023 - 12/2019
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 09/2008
2	Radiation Pneumonitis 03/2024 - 08/2020
2	Adenocarcinoma 10/2023 - 07/2008
2	Lymphatic Metastasis 10/2023 - 01/2022
2	Wounds and Injuries (Trauma) 01/2023 - 01/2020
2	Ischemia 11/2022 - 10/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022 - 01/2021
2	Idiopathic Pulmonary Fibrosis 02/2022 - 01/2021
2	Lung Injury 10/2021 - 01/2021
2	Fistula 02/2021 - 12/2016
2	Fibrosis (Cirrhosis) 01/2021 - 08/2020
2	Rectal Neoplasms (Rectal Cancer) 11/2020 - 02/2017
2	Margins of Excision 03/2020 - 09/2017
2	Stomach Neoplasms (Stomach Cancer) 08/2019 - 04/2018
2	Disease Progression 07/2019 - 06/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2019
2	Carcinogenesis 05/2016 - 01/2008
1	Critical Illness (Critically Ill) 05/2024
1	Postoperative Hemorrhage 04/2024
1	Sepsis (Septicemia) 02/2024
1	Primary Graft Dysfunction 02/2024
1	Acute Lung Injury 02/2024
1	Carcinoma (Carcinomatosis) 01/2024
1	Leiomyosarcoma 12/2023

Drug/Important Bio-Agent (IBA)

19	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2009
16	ErbB Receptors (EGF Receptor)IBA 12/2020 - 07/2008
10	MicroRNAs (MicroRNA)IBA 04/2023 - 08/2011
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2015
8	human ERBB2 proteinIBA 03/2020 - 02/2016
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2007
6	AfatinibIBA 08/2019 - 10/2015
5	Phosphotransferases (Kinase)IBA 02/2022 - 11/2008
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Codon (Codons)IBA 11/2020 - 07/2006
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 09/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2008
3	Monoclonal AntibodiesIBA 10/2021 - 01/2019
3	CytokinesIBA 10/2021 - 05/2016
3	neratinibIBA 03/2020 - 04/2018
2	EnzymesIBA 04/2024 - 07/2006
2	CatecholaminesIBA 04/2024 - 03/2014
2	PeriostinIBA 12/2023 - 12/2023
2	AntibodiesIBA 12/2023 - 12/2021
2	osimertinibIBA 10/2022 - 01/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022 - 03/2009
2	Pemetrexed (MTA)FDA Link 01/2022 - 01/2021
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 12/2021 - 01/2013
2	Carrier Proteins (Binding Protein)IBA 10/2021 - 12/2016
2	Mitogen-Activated Protein KinasesIBA 10/2021 - 11/2008
2	Neutralizing AntibodiesIBA 01/2021 - 01/2019
2	Cell-Free Nucleic AcidsIBA 06/2019 - 12/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2019 - 02/2012
2	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2019 - 11/2008
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
2	CD146 AntigenIBA 01/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 11/2008
2	tyrosine receptor (receptor, tyrosine)IBA 08/2018 - 11/2008
2	Trastuzumab (Herceptin)FDA Link 04/2018 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 12/2016
2	Docetaxel (Taxotere)FDA Link 10/2017 - 09/2017
2	AsbestosIBA 05/2016 - 12/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2016 - 01/2010
2	1-methyl-1-piperidinomethane sulfonateIBA 11/2015 - 11/2008
2	Gefitinib (Iressa)FDA Link 10/2009 - 03/2009
1	Indicators and Reagents (Reagents)IBA 05/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 04/2024
1	Epinephrine (Adrenaline)FDA LinkGeneric 04/2024
1	histidine-rich proteinsIBA 02/2024
1	Glycoproteins (Glycoprotein)IBA 02/2024
1	Plasminogen Activator Inhibitor 1IBA 01/2024
1	CrizotinibIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 12/2023

Therapy/Procedure

18	Therapeutics 01/2024 - 06/2011
12	Chemoradiotherapy 03/2024 - 09/2015
8	Lung Transplantation 05/2024 - 09/2021
4	Adjuvant Chemotherapy 03/2024 - 08/2020
4	Metastasectomy 12/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 10/2023 - 11/2015
3	Operative Time 04/2024 - 01/2023
3	Molecular Targeted Therapy 10/2022 - 03/2009
3	Lymph Node Excision (Lymph Node Dissection) 03/2020 - 07/2008
2	Thoracotomy 10/2023 - 09/2016
2	Resuscitation 01/2023 - 01/2020
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2023
2	Pneumonectomy (Lung Volume Reduction) 02/2021 - 12/2016
2	Sternotomy 09/2016 - 01/2014